L'OCCITANE(00973.HK)第三财季销售净额增长17.9%
格隆汇1月21日丨LOCCITANE(00973.HK)发布公告,2020财年第三季度,集团的销售净额按报告汇率计算增长17.9%,按固定汇率计算增长15.2%。2020财年九个月,集团的销售净额按报告汇率计算增长20.2%,按固定汇率计算增长17.3%。
此外,按品牌划分的增长,LOccitane en Provence于2020财年第三季度持续增长强劲,增长为6.3%,且增长率于年初至今进一步增加至6.0%;Lime Life销售于2020财年第三季度进一步改善11.7%,于2020财年九个月录得稍微正增长;而ELEMIS于2020财年九个月约增长20%(未经审核)。
于2020财年第三季度按地区划分的增长,英国以98.4%增幅领先,其次为中国及美国,分别增长32.4%及22.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.